This Hospital Pharmacy feature is extracted from Off-Label Drug Facts, a publication available from Wolters Kluwer Health. Off-Label Drug Facts is a practitioner-oriented resource for information about specific drug uses that are unapproved by the US Food and Drug Administration. This new guide to the literature enables the health care professional or clinician to quickly identify published studies on off-label uses and determine if a specific use is rational in a patient care scenario. References direct the reader to the full literature for more comprehensive information before patient care decisions are made. Direct questions or comments regarding Off-Label Drug Uses to jgeneral@ku.edu.
Get full access to this article
View all access options for this article.
References
1.
StoneM., FortinP.R., Pacheco-TenaC., InmanR.D.Should tetracycline treatment be used more extensively for rheumatoid arthritis? Meta-analysis demonstrates clinical benefit with reduction in disease activity. J Rheumatol.2003; 30(10): 2112–2122.
2.
KloppenburgM., BreedveldF.C., TerwielJ.P., MalleeC., DijkmansB.A.Minocycline in active rheumatoid arthritis. A double-blind, placebo-controlled trial. Arthritis Rheum.1994; 37(5): 629–636.
3.
TilleyB.C., AlarcónG.S., HeyseS.P.; MIRA Trial Group. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. Ann Intern Med.1995; 22(2): 81–89.
4.
BluhmG.B., SharpJ.T., TilleyB.C.Radiographic results from the Minocycline in Rheumatoid Arthritis (MIRA) Trial. J Rheumatol.1997; 24(7): 1295–1302.
5.
O'DellJ.R., HaireC.E., PalmerW.Treatment of early rheumatoid arthritis with minocycline or placebo: Results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum.1997; 40(5): 842–848.
6.
O'DellJ.R., BlakelyK.W., MallekJ.A.Treatment of early seropositive rheumatoid arthritis: A two-year, double-blind comparison of minocycline and hydroxychloroquine. Arthritis Rheum.2001; 44(10): 2235–2241.
7.
SinghJ.A., SaagK.G., BridgesS.L.Jr2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Rheumatol.2016; 68(1): 1–26.
8.
AssadS.A., BernsteinE.F., BrodB., JamesW.D.Extensive pigmentation secondary to minocycline treatment of rheumatoid arthritis. J Rheumatol.2001; 28(3): 679–682.
